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 Abstract Objective It is not known whether the risk
of recurrence declines with time in bipolar disorders
and in major depression. This study describes the life-
long recurrence risk of bipolar I, bipolar II and major
depressive disorders. Method 160 bipolar-I, 60 bipolar-II
and 186 depressive patients hospitalised between 1959
and 1963 were followed up every five years from 1965 to
1985. The course prior to the index hospitalisation was
assessed in retrospect. The recurrence risk was com-
puted by the multiplicative intensity model (Aalen et al.
1980). Results The cumulative intensity curves for the
transition from states of remission to new episodes re-
mained linear over 30 to 40 years after onset, indicating
a constant risk of recurrence over the life-span up to the
age of 70 or more. The recurrence risk of bipolar disor-
ders (0.40 episodes per year) was about twice that of de-
pression (0.20 episodes per year); BP-II disorders had
only a slightly higher recurrence risk than BP-I disor-
ders. There were no significant gender differences in the
course of either bipolar or depressive disorders. Conclu-
sion If long-term trials confirm its efficacy, these results
support lifelong prophylactic treatment of severe types
of mood disorders.
 Key words bipolar disorder · depressive disorder ·
follow-up · recurrence
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Introduction
Currently many patients with mood disorders receive
long-term medication.If the patient remains well during
maintenance treatment, sooner or later the question
arises whether medication should be titrated and finally
stopped or whether it should be continued, and if so for
how long. Or, is the natural history so poor and the treat-
ment so effective that the medication should be given
lifelong?
Controlled cessation trials have demonstrated high
recurrence risks (review of Suppes et al. 1993) although
they cannot distinguish between rebound effects and
natural history of the disorder.
New, large, case-register studies by Kessing et al.
(1999, 1999, 2001, 2001) based on the recurrence of hos-
pitalisations nation-wide in Denmark found a progres-
sive deterioration in the course. The merit of Kessing’s
analysis, using a frailty model, is that it takes the intra-
individual course into account (Kessing and Andersen
2001). Turvey et al.’s (1999) 10-year prospective natural-
istic study found that the second cycle of bipolar disor-
ders was clearly shorter than the first, the third a little
longer than the second, but the fourth and fifth cycles
were again shorter. In a recent re-analysis of our long-
term follow-up study, using less sensitive non-paramet-
ric statistics, we found in bipolar disorders a systematic
shortening only between cycle 1 and 2; later there was no
clear trend (Angst and Sellaro 2000).
A recent review of two centuries’ literature on the nat-
ural history of bipolar disorder concluded that bipolar
disorder has always been highly recurrent and consid-
ered to have a poor prognosis, and that the findings of
modern follow-up studies are closely compatible with
those of studies conducted before the introduction of
modern antidepressant and mood-stabilising treat-
ments (Angst and Sellaro 2000). But what is the long-
term prognosis of recurrent mood disorders in general?
The main question is whether multiple past episodes
are a risk factor for future recurrences and whether the
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risk of recurrence remains constant, without great
changes in the long term, or whether it may decrease
spontaneously, especially in the elderly. The question is
of practical importance for treatment decisions and is
also justified because the cycle length (time from onset
of one episode to the onset of the next) is known to
shorten at the beginning of mood disorders; the second
cycle is usually shorter than the first (Angst and Sellaro
2000). Our original assumption that this shortening
would continue over many cycles and finally reach a cer-
tain limit was questioned by several studies: Fukuda
et al. (1983), Coryell and Winokur (1992), Solomon et al.
(1995), Kessing et al. (1998); the controversy was sum-
marised in a review by Suppes et al. (2000) and in the
very comprehensive review of Marneros and Brieger
(2002)).
From a methodological point of view it is important to
control for the number of episodes, because patients
with a history of multiple episodes tend to have shorter
cycles/intervals in the future than those with a few;
therefore one should break down the total sample into
cohorts stratified by the total number of episodes (Slater
1938). One can also base analyses on intra-individual
logarithmic means of cycle length because both length
of episodes and cycles are log-normally distributed
(Angst and Weis 1967).
So far, most studies of the recurrence risk of mood
disorders have been descriptive, counting the number of
recurrences as a function of follow-up duration or num-
ber of episodes per year (Marneros et al. 1988). The lat-
ter authors found an annual frequency of episodes of
0.23 for bipolar and 0.12 for depressive disorders
(Marneros et al. 1991). The counting method does not
take into consideration the fact that the patient is only at
risk of recurrence during the inter-episode period, and
therefore underestimates the force of morbidity.
A further methodological progress came with the pa-
per of Lavori et al. (1996) which introduced survival
analysis for repeated events into psychiatry. In their 10-
year prospective study of 173 bipolar and 555 depressive
patients the authors found a persistence risk of well to ill
transitions (recurrences) in both groups and estimated
that the cumulative intensity was about double that in
the bipolar than in the depressed group. They concluded
that the transitions continued in both groups, suggest-
ing that over ten years the two disorders neither “burn
out” nor “spiral into chronicity”.
The most recent methodological progress was intro-
duced by Kessing et al. (1999, 2001), who applied frailty
models (Andersen et al. 1993) taking the intra-individ-
ual course into account, and by Solomon et al. (2000),
both of whom showed progressive recurrence with in-
creasing number of episodes.
The purpose of this first of two papers is to analyse
the risk of recurrence of depression and bipolar disor-
ders over a period of decades on the basis of a life-long
follow-up and to answer the question: is recurrence con-
stant or does it increase or decrease over the life-span?
Methods
 Sample and diagnoses
The sample consists of 160 bipolar-I patients, 60 bipolar-II patients
and 186 unipolar depressive patients, who were admitted between
1959 and 1963 to the Zurich University Psychiatric Hospital with a di-
agnosis of mania, endogenous depression, endo-reactive depression,
manic-depressive disorder, or affective disorder with mood-congru-
ent or mood-incongruent psychotic features (hallucinations or delu-
sions) including schizo-affective disorder. The diagnoses of bipolar
disorder took the lifetime course into account. Of the patients 61 %
met criteria for psychosis over lifetime, which underlines the fact that
we are dealing with a seriously ill hospitalised group (Angst and
Preisig 1995a). The distinction between mania and hypomania and
between severe and mild depression was made on the basis of the
need for hospitalisation, as originally suggested by Dunner, Fleiss and
Fieve (1976) in their definition of bipolar II disorder. The softer, DSM
criteria for BP-II disorders could not be applied in retrospect using all
available sources (records, reports of doctors, relatives and the pa-
tients). Bipolarity was assumed as soon as hypomania occurred for a
few days, regardless of whether it seemed to be drug-induced or not.
Early onset was defined by an onset before the age of 40, late onset at
the age of 40 or more. Follow-ups were carried out in 1963, 1965, 1970,
1975, 1980 and 1985; data on mortality were collected in 1991 and
1997 (Angst et al.2002).The course was assessed in retrospect by fam-
ily doctors’ reports, records of in- and outpatient services and reports
by patients and significant others. A detailed description of the sam-
ple, all subjects of which qualified also for modern criteria for major
depression can be found in Angst and Preisig (1995a). In addition ex-
tensive descriptive data on the course of this sample were published
by Angst and Preisig (1995b) and will not be summarised again in this
paper, which will focus exclusively on the recurrence risk.
 Measures
Length of episodes was measured in months and weeks and length of
cycles in months.Biphasic episodes shifting for instance from depres-
sion to hypomania were counted as one episode. The time spent in ill-
ness was calculated by duration of illness divided by length of obser-
vation since onset.Outcome was measured at the last interview in 1985
by the Global Assessment Scale (GAS) of Endicott et al.(1976).Two rat-
ings were made in cases of an actually running episode: a GAS rating
of the actual state and one before the last episode.Residual states were
defined by GAS scores and duration in years. Chronicity was defined
as the last episode without recovery over at least two years.
 Statistics
The recurrence risk was computed by the multiplicative intensity
model (Aalen et al. 1980), a method which was introduced for this
purpose into psychiatry by Andersen and Rasmussen (1986) and La-
vori et al. (1996). The computer program was provided by Lavori. All
computations were based on follow-up in years since the first onset of
the disorders.
For Table 1 chi square statistics were used for categorical data and
non-parametric analyses of variance (Kruskal-Wallis test) were ap-
plied for continuous measures.
Results
 Descriptive course characteristics of the samples
The subgroups consisted of 186 unipolar major depres-
sives, 160 bipolar I and 60 bipolar II patients; the latter
group was 87 % female (Table 1).
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At the last follow-up in 1985 BP-I subjects were sig-
nificantly younger, but they had an earlier age of onset
than the other two groups,which also explains their long
observation time and duration of the illness. BP-II pa-
tients took an intermediate position in age of onset and
length of observation. A total of 40 % of patients had
died; suicide occurred slightly (n. s.) more often among
MDD than bipolar patients. Time spent in illness was
about 20 % of lifetime after onset and did not vary be-
tween the groups.
The course variables demonstrate that the two BP
subgroups took a similar course but differed clearly
from MDD. The two BP groups had a much higher total
number of episodes and annual episode frequencies and
shorter episode and cycle lengths.
The outcome, assessed by the GAS, was best in MDD
and worst in BP-I patients, whereas BP-II cases took an
intermediate position.
 Bipolar disorder vs. depression
Fig. 1 shows the cumulative intensity curves of the tran-
sition from states of remission to new episodes. The data
can be interpreted over 40 years of follow-up; during
that long period there was no substantial change in the
recurrence risk indicated by the linear lines in both
bipolar and unipolar depressive disorders. The cumula-
tive intensity is much higher in bipolars, indicating a
doubled recurrence risk.
 Bipolar I vs. Bipolar II disorders
Fig. 2, which shows the cumulative risk with 95 % confi-
dence intervals, demonstrates a slightly but significantly
higher recurrence risk of BP II versus BP I disorders,
persisting over decades.
MDD BP-II BP-I Test df P
statistic
N 186 60 160
% % % χ2
Male 22.6 13.3 40.6 21.6 2 < 0.001
Early onset (< 40 years) 38.2 61.7 76.3 51.5 2 < 0.0001
Dead by 1985 43.6 41.7 41.3 4.7 4 0.32
Suicide by 1985 13.4 6.7 8.1 3.6 2 0.16
Psychotic symptoms 50.5 43.3 78.8 37.5 2 < 0.001
Median Median Median Kruskal-
Wallis
Age of onset 46.0 37.0 26.5 63.9 2 < 0.001
Age at follow-up 70.5 72.5 65.0 20.6 2 < 0.001
# episodes 4.0 10.5 10.0 119.7 2 < 0.001
# episodes per year 0.2 0.3 0.4 45.5 2 < 0.001
Length of episodes (months) 5.4 4.0 4.2 10.1 2 0.006
Length of cycles (months) 56.5 36.4 33.0 46.5 2 < 0.001
Total length of observation (months) 291.5 362.0 387.0 38.2 2 < 0.001
Duration of illness 211.5 313.5 338.5 52.3 2 < 0.001
Time spent in illness (mean %) 21.0 19.0 19.0 5.0 2 0.08
% % % χ2
Outcome 25.1 10 0.005
GAS ≥ 61 & ≥ 5 years 25.8 18.3 15.1
GAS ≥ 61 & < 5 years 25.3 35.0 22.1
GAS 1–60 & ≥ 5 years 9.1 6.7 8.2
GAS 1–60 & < 5 years 14.5 18.3 32.7
Chronic 11.8 15.0 13.8
Suicide 13.4 6.7 8.2
GAS Global Assessment Scale (Endicott et al. (1976–7997)
Table 1 Characteristics of the sample
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 Bipolar disorder and gender
Fig. 3 shows the transitions from healthy to ill for both
women and men with bipolar disorder; women tend to
have a slightly higher recurrence risk than men, but the
two curves do not differ significantly.
 Depression and gender
Fig. 4 shows no evidence of a gender difference in the re-
currence risk of severe major depressives. This re-
mained true when the patients were in their sixties and
seventies.
 Age of onset and recurrence
For this analysis early onset (before the age of 40) and
late onset disorders (bipolars and depressives) were
considered; no significant differences in recurrence
were found (results not shown).
Discussion
In practice, the decision how long to continue a mainte-
nance medication has to be made on the basis of two
questions: 1) what is the naturalistic prognosis of the
specific mood disorder from which the patient is suffer-
ing? and 2) how severe were the individual previous his-
tory of the illness and its social consequences before the
prophylactic medication was started? This paper can
only contribute to answering the first question.
Our data confirm again that the recurrence risk of
bipolar disorders is about double that of major depres-
sion. Most important is the replication of a constant re-
currence risk first demonstrated convincingly by Lavori
et al. (1996) over a period of ten years and our finding
that this period can be extended to at least 40 years of
Fig. 1 Bipolar disorder vs. unipolar disorder (vertical bars indicate 95 % confi-
dence intervals)
Fig. 2 Bipolar I disorder vs. bipolar II disorder (vertical bars indicate 95% confi-
dence intervals)
Fig. 3 Bipolar disorders divided into men and women (vertical bars indicate 95%
confidence intervals)
Fig. 4 Major depressive disorders
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follow-up.It is of further interest that the recurrence risk
remains constant over the life-span in both bipolar dis-
order and depression, although the two groups differ as
regards the magnitude of that risk. We found no clear
gender difference either in recurrence or between early
and late onset cases.
A further important finding is the great similarity be-
tween the recurrence risk of BP-I and BP-II disorders,al-
though the latter have a slightly poorer prognosis. The
recurrence risk in BP-II disorder was markedly higher
than in major depressive disorders,pointing to the para-
mount importance of distinguishing BP-II from unipo-
lar MDD. There is new evidence for the assumption that
BP-II disorders are very frequently misdiagnosed as
MDD even by psychiatrists (Hantouche and Akiskal
1998) and that the current diagnostic criteria for hypo-
mania may be too strict (Angst 2002).
Our findings that the risk of recurrence remains con-
stant are in line with survival analyses of the mortality
of the same patient samples, which showed that the sui-
cide risk in mood disorders persisted over decades up to
the age of about 70 (Angst et al. 2002).
This study has certain limitations in that it deals with
severe, hospitalised cases of mood disorders and follow-
up was only possible at five-year intervals. Between the
follow-ups the course was assessed in retrospect. The
strength of the study is that it is a lifelong follow-up.
In conclusion our finding of a lifelong constant re-
currence risk of mood disorders together with the re-
sults of Kessing et al. (1999) and Solomon et al. (1995) in-
dicating a progression of the disorder with increasing
number of episodes suggests the continuing need for
anti-recurrence prophylaxis over the entire lifespan.
Whether this need for secondary prevention is met by
current medications and psychosocial interventions is a
question for appropriately targeted clinical trials.
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